Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...
We recently attended the annual REITWeek conference in New York City, where we conducted 39 management meetings, toured ...
There is no doubt that Adobe is cheap at current levels. The stock is trading at a forward P/E of 9 and a P/FCF of 11, if SBC ...
As truckload capacity tightens and regulatory enforcement continues to reshape the market, industry analysts say carriers have regained pricing power, creating higher rates, greater service pressures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results